DOCSLIB.ORG

Patient Safety Regulation in the NHS: Mapping the Regulatory Landscape of Healthcare

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Patient Safety Regulation in the NHS: Mapping the Regulatory Landscape of Healthcare Open access Research BMJ Open: first published as 10.1136/bmjopen-2018-028663 on 9 July 2019. Downloaded from Patient safety regulation in the NHS: mapping the regulatory landscape of healthcare Eirini Oikonomou,1 Jane Carthey,2 Carl Macrae,3 Charles Vincent1 To cite: Oikonomou E, ABSTRACT Strengths and limitations of this study Carthey J, Macrae C, et al. Objectives The current research project sought to map Patient safety regulation out the regulatory landscape for patient safety in the ► This is the first study to attempt a complete mapping in the NHS: mapping the English National Health Service (NHS). regulatory landscape of of all organisations engaged in regulatory activities Method We used a systematic desk-based search healthcare. BMJ Open in the NHS. using a variety of sources to identify the total number of 2019;9:e028663. doi:10.1136/ ► We have included all statutory regulators but also organisations with regulatory influence in the NHS; we bmjopen-2018-028663 many others who may not see themselves as regula- researched publicly available documents listing external tors but nevertheless carry out regulatory activities. ► Prepublication history and inspection agencies, participated in advisory consultations ► Understanding the full regulatory landscape enables additional material for this paper with NHS regulatory compliance teams and reviewed the are available online. To view more precise assessment of the benefits and costs websites of all regulatory agencies. please visit the journal (http:// of regulation. Results Our mapping revealed over 126 organisations dx. doi. org/ 10. 1136/ bmjopen- ► Due to resource constraints, we were only able to who exert some regulatory influence on NHS provider 2018- 028663). identify regulatory activities from the websites of the organisations in addition to 211 Clinical Commissioning relevant organisations. Received 14 January 2019 Groups. The majority of these organisations set standards ► Although we have searched extensively, we cannot Revised 4 April 2019 and collect data from provider organisations and a be sure that this is a complete mapping. Accepted 13 June 2019 considerable number carry out investigations. We found a multitude of overlapping functions and activities. The variability in approach and overlapping functions suggest regulation may have valuable effects, it is that there is no overall integrated regulatory approach. 2 3 Conclusion Regulation potentially provides a variety of too often ineffective, inflexible and gener- benefits in terms of maintaining the safety and quality ates ticking box behaviour and bureaucratic http://bmjopen.bmj.com/ 4 of care by providing an external perspective on the care compliance. being delivered. However, the variability, extent and A number of organisations and commenta- fragmentation of the regulatory system of the NHS make it tors have called for reform, proposing that the hard for regulators to act effectively and places a massive regulatory system needs to be simpler, organ- burden on NHS provider organisations. Overlapping ised around a common approach to regula- regulatory requests may distract locally driven initiatives tion and less burdensome for providers.5 6 to improve safety and quality. Further research is needed However, before such broad proposals can be to understand the full extent of regulatory activity and the true benefits and costs incurred. given, proper consideration of a fundamental on October 25, 2020 by guest. Protected copyright. question must be addressed. What is the nature and extent of the current system? In this study, we aimed to map the current regu- INTRODUCTION latory system for patient safety in the NHS, Regulation is one important means of moni- © Author(s) (or their including both statutory regulators and other employer(s)) 2019. Re-use toring and improving the safety of healthcare organisations with regulatory influence. permitted under CC BY-NC. No with the aim of ensuring safe, reliable treat- Understanding this landscape of regulation commercial re-use. See rights ment for patients and a safe working environ- of safety is an essential preliminary to any and permissions. Published by ment for healthcare professionals. Regulation BMJ. rational reform of the regulatory system but in healthcare takes a variety of different 1Experimental Psychology, has, to our knowledge, never been previously University of Oxford, Oxford, UK forms and is conducted by many different attempted. 2Jane Carthey Consulting, actors, from formal regulatory inspections to London, UK voluntary efforts to promote good practice. Regulation, regulators and patient safety 3Business School, University of Regulatory processes and activities poten- The term ‘regulation’ can be viewed nega- Nottingham, Nottingham, UK tially provide valuable feedback to provider tively and narrowly by those who are subject 7 Correspondence to organisations, supporting improvement and to regulatory oversight. In healthcare Miss Eirini Oikonomou; ensuring that high standards of performance settings in particular, regulation can often be Eirini. oikonomou@ psy. ox. ac. uk are maintained.1 Critics argue that although seen as intrusive and inefficient interference Oikonomou E, et al. BMJ Open 2019;9:e028663. doi:10.1136/bmjopen-2018-028663 1 Open access by external authorities that distracts from the important which had failed to detect and respond to early signs BMJ Open: first published as 10.1136/bmjopen-2018-028663 on 9 July 2019. Downloaded from tasks of clinical care.8 However, activities of regulation of organisational failure.16 The governmental response are typically much broader and more constructive than generated more structural changes to the system, with an this.9 10 Regulation represents a wide range of different increased focus on devolution of central oversight. activities that seek to shape motives and attitudes within The evolution of regulation in the NHS needs to be organisations, as well as policies and protocols.11 In seen in the context of continual widespread reform and healthcare, regulatory activities can encompass every- restructuring of the wider NHS. In 2002, the National thing from formal regulatory inspections, attempts to Health Service Reform and Healthcare Professionals promote good practice, to efforts to support and initiate Act merged 95 health authorities into 28 strategic health culture improvement.12 13 Moreover, regulatory activities authorities (SHAs).17 In 2006, the number of SHAs are commonly engaged in by a diverse range of different reduced to 10 and later transformed into four clusters actors and institutions across healthcare, from statutory (North, South, Midlands and East of England) before regulators to national agencies to professional bodies finally been abolished in April 2013.18 During this time, and charitable organisations. health services commissioning was undertaken by 481 The regulatory landscape of healthcare is therefore Primary Care Groups, later reduced to 152 Primary complex and multifacetted. To begin mapping the Care Trusts (PCTs) in 2002, solely responsible for all current regulatory system around patient safety, it is NHS commissioning.17 Finally, under the Health and necessary to define the scope of our enquiries. In this Social Care Act in 2012, PCTs were replaced by statutory, study, we define patient safety regulation as the processes commissioning ‘consortia’, the Clinical Commissioning engaged in by institutional actors that seek to shape, monitor, Groups (CCGs).19 control or modify activities within healthcare organisations in The 5-year forward review20 brought the planning and order to reduce the risk of patients being harmed during their care. regulation of primary, secondary and social care together This definition aims to focus attention on the specific with local authority influence under seven models of care activities that are engaged in by ‘external’ actors to influ- each covering a core set of related services (for instance, ence ‘internal’ processes of patient safety in healthcare urgent and emergency care networks). Local leaders in organisations. It also aims to encompass the breadth of 44 geographical areas have been asked to design sustain- diverse institutional actors that engage in these processes ability and transformation plans (STPs) to demonstrate of regulation, even when some of those actors may not how they intend to transform services in their local define themselves as formal ‘regulators’. areas.21 Ten integrated care systems (ICSs) have evolved from STPs, responsible for planning and commissioning Evolution of regulation in the NHS care for their populations.22 Before continuing to the mapping process, it is important http://bmjopen.bmj.com/ to provide a brief historical perspective on regulation The need to map the regulatory landscape of the NHS across the NHS. The 1944 National Health Service White This short overview of regulation history in the UK Paper recognised that regular inspections of hospitals demonstrates a stream of structural reforms over the would be valuable but the first true external oversight last 25+ years, which have gradually increased the extent body was not established until 1969, following a series of and complexity of the regulatory structures.16 23 In 2002, healthcare scandals.14 Until the late 1970s, the Depart- Walshe argued that: ‘Current regulators vary widely in ment of Health fulfilled most of the regulatory functions, their statutory authority, powers, scope of action, and but between 1979 and 1997, the
Load more

Recommended publications
  • Reporting and Rating NHS Trusts' Use of Resources
    Summary of consultation responses: Reporting and rating of NHS trusts’ use of resources March 2018 Contents 1. Introduction and overview ................................................................................... 3 2. Key themes of the consultation .......................................................................... 7 2.1 Introduction ........................................................................................................ 7 2.2 A transparent and streamlined approach to working together ........................... 8 What you said ....................................................................................................... 8 What we will do .................................................................................................... 9 2.3 A clear approach to displaying and communicating the new assessments and ratings .................................................................................................................... 11 What you said ..................................................................................................... 11 What we will do .................................................................................................. 12 2.4 Fair, proportionate and consistent rules for combining the Use of Resources rating with CQC’s existing quality ratings ............................................................... 13 What you said ..................................................................................................... 13 What we will do .................................................................................................
    [Show full text]
  • Clinical Negligence Cases in the English NHS: Uncertainty in Evidence As a Driver of Settlement Costs and Societal Outcomes
    Health Economics, Policy and Law (2021), page 1 of 16 doi:10.1017/S1744133121000177 ARTICLE Clinical negligence cases in the English NHS: uncertainty in evidence as a driver of settlement costs and societal outcomes Alexander W. Carter1* , Elias Mossialos1,2 , Julian Redhead3 and Vassilios Papalois3,4 1Department of Health Policy, London School of Economics & Political Science, London, UK, 2Institute of Global Health Innovation, Imperial College London, London, UK, 3Imperial College Healthcare NHS Trust, London, UK and 4Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, UK *Corresponding author. Email: [email protected] (Received 1 May 2020; revised 15 March 2021; accepted 17 March 2021) Abstract The cost of clinical negligence claims continues to rise, despite efforts to reduce this now ageing burden to the National Health Service (NHS) in England. From a welfarist perspective, reforms are needed to reduce avoidable harm to patients and to settle claims fairly for both claimants and society. Uncertainty in the estimation of quanta of damages, better known as financial settlements, is an important yet poorly char- acterised driver of societal outcomes. This reflects wider limitations to evidence informing clinical negli- gence policy, which has been discussed in recent literature. There is an acute need for practicable, evidence-based solutions that address clinical negligence issues, and these should complement long-stand- ing efforts to improve patient safety. Using 15 claim cases from one NHS Trust between 2004 and 2016, the quality of evidence informing claims was appraised using methods from evidence-based medicine. Most of the evidence informing clinical negligence claims was found to be the lowest quality possible (expert opinion).
    [Show full text]
  • Oversight of NHS-Controlled Providers: Guidance February 2018
    Oversight of NHS-controlled providers: guidance February 2018 We support providers to give patients safe, high quality, compassionate care within local health systems that are financially sustainable. Contents 1. Summary ................................................................................... 2 2. Our oversight of NHS-controlled providers ................................ 3 Annex A: NHS-controlled provider licence conditions .................... 7 1 | > Contents 1. Summary The NHS provider licence is a key part of NHS Improvement’s regulatory and oversight system (in this document, references to NHS Improvement are to Monitor and the NHS Trust Development Authority, TDA). Following the Health and Social Care Act 2012 (the Act), Monitor consulted on the first set of provider licence conditions for NHS foundation trusts and independent providers in 2013 and started issuing licences to foundation trusts in April 2013. Independent providers have been required to hold a licence since April 2014. Although NHS trusts are not legally required to hold a licence, in practice NHS Improvement applies the key conditions of the licence to NHS trusts, in line with the principles of the Single Oversight Framework (SOF) for NHS trusts and foundation trusts (collectively referred to as NHS providers). Following consultation between 13 September and 12 October 2017, we are extending our oversight of NHS-controlled providers, as outlined in section 2. 2 | > Oversight of NHS-controlled providers: our policy position 2. Our oversight of NHS- controlled providers 2.1 Why oversee NHS-controlled providers? NHS foundation trusts’ principal purpose is to provide goods and services for the purposes of the NHS in England. They are not-for-profit, public benefit corporations created to devolve decision-making from central government to local organisations and communities.
    [Show full text]
  • Developing a Patient Safety Strategy for the NHS Proposals for Consultation
    Developing a patient safety strategy for the NHS Proposals for consultation December 2018 We support providers to give patients safe, high quality, compassionate care within local health systems that are financially sustainable. Contents The purpose of this consultation ..................................................... 2 Background ..................................................................................... 3 What is patient safety? .......................................................................................... 3 Who are the national patient safety team? ............................................................ 3 Where are we now? .............................................................................................. 4 Our challenges ...................................................................................................... 5 Our proposed aims and principles .................................................. 7 A just culture .......................................................................................................... 7 Openness and transparency ................................................................................. 8 Continuous improvement ...................................................................................... 8 What we are proposing ................................................................. 10 Context ................................................................................................................ 10 Insight .................................................................................................................
    [Show full text]
  • HEE Business Plan 2019/20
    Health Education England Health Education England Business Plan 2019/20 Developing people for health and healthcare www.hee.nhs.uk Contents Foreword .....................................................................................................................4 Introduction .................................................................................................................6 Section 1 - HEE Strategic Goals and Core Responsibilities .......................................7 Section 2 - HEE Action Plan 2019/20 ........................................................................12 Section 3 - Financial Requirements ..........................................................................24 Section 4 - Strategic Context ....................................................................................26 Section 5 - About HEE ...............................................................................................27 Section 6 - Enablers of Change ................................................................................32 Section 7 - Strategies and Subsidiary Plans ............................................................34 Section 8 - Information Strategy .............................................................................36 Section 9 - Performance Reporting ..........................................................................37 Section 10 - Contact Information .............................................................................40 3 Foreword Foreword from our Chairman and Going
    [Show full text]
  • Agency Staff in the NHS
    This is a repository copy of Agency staff in the NHS. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/150202/ Book Section: Grasic, Katja (2016) Agency staff in the NHS. In: Curtis, Lesley and Burns, Amanda, (eds.) Unit Costs of Health and Social Care 2016. Personal Social Services Research Unit, University of Kent at Canterbury , p. 7. Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Unit Costs of Health and Social Care 2016 7 Agency staff in the NHS Katja Grasic Introduction The quality of care and safety of patients in NHS hospitals depend on having an adequate number of skilled healthcare professionals. Growing shortages of qualified clinical and non-clinical staff have led to increasing reliance on agency staff to resolve staffing shortfalls and ensure safe staffing numbers. This has engendered a rapid growth in agency expenditure, and contributed to deficits in hospital budgets (King’s Fund, 2015a).
    [Show full text]
  • Health Education England Annual Report and Accounts 2020-21
    Annual Report and Accounts 2020-21 Health Education England (Executive Non-Departmental Public Body) www.hee.nhs.uk We work with partners to plan, recruit, educate and train the health workforce. HC 266 Health Education England (Executive Non-Departmental Public Body) Annual Report and Accounts 2020-21 Presented to Parliament pursuant to Paragraph 26 (4) of Schedule 5 of the Care Act 2014 Ordered by the House of Commons to be printed on 15 July 2021 HC 266 © Crown copyright 2021 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at www.gov.uk/official-documents Any enquiries regarding this publication should be sent to us via www.hee.nhs.uk ISBN 978-1-5286-2444-2 CCS0221001382 06/21 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group on behalf of the Controller of Her Majesty’s Stationery Office About Health Education England Health Education England exists for one reason only: our vision is to help improve the quality of life and health and care services for the people of England by ensuring the workforce of today and tomorrow has the right skills, values and behaviours, in the right numbers, at the right time and in the right place. Our purpose as part of the NHS, is We serve … to work with partners to plan, recruit, educate and train the health workforce.
    [Show full text]
  • NHS England and NHS Improvement Is the Umbrella Body That Oversees Healthcare
    “No society can legitimately call itself civilised if a sick person is denied medical aid because of lack of means” 1962 hospital 1990 internal 2012 Lansley 2019 long plan market reforms term plan NHS is 1974 health 2000 NHS 2014 5-year born authorities plan forward view • Medicines & Healthcare products • NHS Blood and Transplant Regulatory Agency • NHS Business Services Authority • Public Health England • NHS Resolution • NHS Counter Fraud Authority Commissioners Central Support and Improvement Regulators • NHS England/NHS Improvement • National Institute of Health and Care Excellence • Care Quality Commission • Health Education England • NHS England/NHS Improvement • NHS Digital • Human Fertilisation and Embryology Authority • Human Tissue Authority • Health Research Authority ▪ The Department for Health and Social Care is the government department responsible for funding and coming up with policies to do with healthcare in the UK. ▪ NHS England and NHS Improvement is the umbrella body that oversees healthcare. It is an independent body, which means that the Department for Health cannot interfere directly with its decisions. ▪ Clinical Commissioning Groups (CCGs) are responsible for commissioning healthcare for their local area. They are run by GPs, nurses and consultants who assess local health needs and commission the services to meet them. They are in charge of around 60% of the NHS budget. ▪ NHS Foundation Trusts and NHS Trusts provide the care that the CCGs commission. They include hospital, ambulance, mental health, social care
    [Show full text]
  • Dear Dido I Am Writing to You to Confirm NHS Improvement's Current Objectives and the Schedule of Meetings Through Which You W
    Philip Dunne MP Minister of State for Health Richmond House 79 Whitehall London SW1A 2NS Baroness Dido Harding Tel: 020 7210 4850 Chair, NHS Improvement Wellington House 133-155 Waterloo Road London, SE1 8UG 21 December 2017 Dear Dido I am writing to you to confirm NHS Improvement’s current objectives and the schedule of meetings through which you will be held to account for delivery. NHS Improvement’s objectives from now until 2020 are aligned with the health sector’s Shared De- livery Plan which outlines the Government’s priorities for health and care services. In delivering these objectives NHS Improvement is expected to continue to take a health-economy wide approach to ensuring clinically and financially sustainable health services which improve overall health outcomes and reduce health inequalities. NHS Improvement will also need to estab- lish and foster close and effective working relationships with NHS England, Health Education Eng- land (HEE), other national NHS bodies, and with the provider sector in order to drive improvements throughout the sector. Key to NHS Improvement’s success will be its delivery of a balanced NHS budget whilst driving improvements in the efficient use of resources and increasing productivity in NHS providers. To achieve this, the support provided by NHS Improvement to the provider sector must continue to be tailored to the needs of the sector and to the very specific, differing needs of the organisations that it comprises. We will continue to hold you to account through a series of formal meetings. At mid-year and end- of-year Ministerial accountability meetings will be held.
    [Show full text]
  • Health Education England's Written Evidence for 2021/22 March 2021
    NHS Pay Review Body Health Education England’s written evidence for 2021/22 March 2021 (LEAVE BLANK) March 2021 Page 2 of 15 1. Introduction 1.1. Health Education England (HEE) welcomes the opportunity to submit evidence to The NHS Pay Review Body (NHS PRB) as part of its national process of gathering evidence from interested parties to inform the recommendations for 2021/22. 1.2. HEE’s evidence provides an update on our key areas of responsibility, namely medical trainee recruitment and our range of initiatives to drive reform in postgraduate medical education. We have also included information on the impact of COVID-19 and the resultant and associated financial challenges. 1.3. Our evidence has been provided in the light of the broad strategy outlined in the NHS Long Term Plan and We are the NHS: People Plan for 2020/21. 2. Health Education England 2.1. HEE was created by the NHS reforms of 2012 which abolished Strategic Health Authorities (SHAs) and Primary Care Trusts (PCTs). The functions of these organisations were given to new bodies including the NHS Commissioning Board, Clinical Commissioning Groups, The Trust Development Authority, and to HEE. HEE was originally created as a Special Health Authority in 2013 and was formalised by the Care Act 2014 as a statutory Arm’s Length Body of the Department of Health and Social Care. 2.2. HEE is the NHS body that works with others to plan, educate and train the health workforce. To deliver this purpose, HEE: • seeks out, invests in and quality assures the best education and training for trainees, new roles and current professionals; intervening where quality, environment or supply are not meeting the needs of learners or the NHS; • ensures new evidence-based science, digital technology, skills and knowledge enhance both individual staff and multi-professional teams; • co-operates and collaborates with partners across health and education, respecting each other’s roles, expertise and responsibilities.
    [Show full text]
  • Information Governance Operating Model 2020-2022
    INFORMATION GOVERNANCE OPERATING MODEL 2020 - 2022 Corporate Information Governance, NHS England and NHS Improvement Information Governance Policy Team, NHSX NHS England and NHS Improvement Enabling a lawful and ethical culture for the use of information to deliver and improve our high-quality patient care Contents 1. Executive summary ......................................................................................................................................... 3 2. Introduction ....................................................................................................................................................... 4 3. IG responsibility scope .................................................................................................................................. 5 4. Joint working .................................................................................................................................................. 10 5. Corporate IG team ......................................................................................................................................... 11 6. IG Policy team (NHSX) .................................................................................................................................. 19 7. Governance framework ................................................................................................................................ 22 Appendix A – Corporate IG structure ..............................................................................................................
    [Show full text]
  • Achieving a Digital NHS Lessons for National Policy from the Acute Sector
    Research report May 2019 Achieving a digital NHS Lessons for national policy from the acute sector Sophie Castle-Clarke and Rachel Hutchings Acknowledgements We are grateful to everyone at the trusts we visited who participated in our interviews and focus groups and supported the organisation of our visits. We are also grateful to all of the individuals who participated in the scoping conversations and the policy workshop. Special thanks to the reviewers who provided comments on an earlier draft including Helen Buckingham (Director of Strategy and Operations, Nuffield Trust), Nigel Edwards (Chief Executive Officer, Nuffield Trust), Harry Evans (Researcher, The King’s Fund), John Farenden (Senior Programme Lead, Local Health and Care Record Programme, NHS England), Iain Fletcher (Senior Programme Lead for Blueprinting, Global Digital Exemplar Programme, NHS England), Lorraine Foley (Chief Executive, Professional Record Standards Body), James Freed (Chief Information Officer, Health Education England), Dr Charles Gutteridge (Chief Clinical Information Officer, Barts Health NHS Trust), Dr Sarah Scobie (Deputy Director of Research) and Ann Slee (Associate Chief Clinical Information Officer (Medicines) and e-prescribing lead, NHS England). With particular thanks to Rob Parker (Associate Chief Information Officer, NHS England) for his continued support and assistance with the project. Finally, we are grateful for the small contribution NHS England made to the funding of this project. Find out more online at: www.nuffieldtrust.org.uk/research Contents Foreword 2 Summary 3 Introduction 9 1 The role of national policy in achieving a digital health system 13 2 Configuring a digital workforce 31 3 Working with digital suppliers 49 4 Making use of data across the system 56 5 Funding and sustainability 65 6 Reflecting on the Global Digital Exemplar and Fast Follower programme 74 7 Concluding thoughts 86 Glossary 89 References 94 Achieving a digital NHS 1 1 2 3 4 5 6 7 Foreword Digitising the NHS has been an important goal of national policy for many years.
    [Show full text]